Literature DB >> 21676047

Safety and efficacy of high-intensity focused ultrasound atop coronary arteries during epicardial catheter ablation.

Jacob S Koruth1, Srinivas Dukkipati, Roger G Carrillo, James Coffey, Jennifer Teng, Thomas B Eby, Vivek Y Reddy, Andre D'Avila.   

Abstract

BACKGROUND: Coronary arterial injury continues to be a limitation of epicardial catheter ablation using currently available energy sources. Application of high intensity focused ultrasound (HIFU) energy may avoid such injury due to its theoretical ability to focus energy beyond the ablation element and create lesions at depth.
OBJECTIVE: This study evaluated the safety of HIFU applications delivered directly over the left anterior descending (LAD) artery in an open-chest swine model.
METHODS: Ten swine underwent median sternotomy. A prototype HIFU probe was placed atop the LAD. Forty-three therapies along the LAD (60-seconds/6 watt) were analyzed. Three, 3, and 4 swine were studied at 2, 4, and 8 weeks and subsequently sacrificed. Lesions were scored (0-4) depending on the percent circumferential involvement of arteries.
RESULTS: Lesion area increased minimally from 54.5 ± 18.0 mm(2) at 2 weeks to 56.9 ± 20.6 mm(2) at 8 weeks, and depth increased moderately from 13.2 ± 2.5 mm to 15.5 ± 3.4 mm. At 2, 4, and 8 weeks, the mean injury score of the LAD was 0.8 ± 0.3, 1.5 ± 0.9, and 2.0 ± 0.7. No/minimal arterial injury was seen in 64% of all sections. However, a progressive increase in injury resulted in 89% of all sections showing any injury at 8 weeks. One animal developed occlusion of the distal LAD.
CONCLUSIONS: HIFU has the potential to create deep ventricular lesions with relative sparing of the LAD. The incremental arterial damage noted over time warrants further evaluation to support the viability of focusing ultrasound energy beyond vulnerable critical structures to ablate deeper targets.
© 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2011        PMID: 21676047     DOI: 10.1111/j.1540-8167.2011.02084.x

Source DB:  PubMed          Journal:  J Cardiovasc Electrophysiol        ISSN: 1045-3873


  8 in total

1.  Retrograde Coronary Venous Ethanol Infusion for Ablation of Refractory Ventricular Tachycardia.

Authors:  Bahij Kreidieh; Moisés Rodríguez-Mañero; Paul Schurmann; Sergio Hugo Ibarra-Cortez; Amish S Dave; Miguel Valderrábano
Journal:  Circ Arrhythm Electrophysiol       Date:  2016-07

Review 2.  Catheter-based ultrasound technology for image-guided thermal therapy: current technology and applications.

Authors:  Vasant A Salgaonkar; Chris J Diederich
Journal:  Int J Hyperthermia       Date:  2015-03-23       Impact factor: 3.914

Review 3.  Emerging non-cancer applications of therapeutic ultrasound.

Authors:  Meaghan A O'Reilly; Kullervo Hynynen
Journal:  Int J Hyperthermia       Date:  2015-03-20       Impact factor: 3.914

Review 4.  Cardiovascular applications of therapeutic ultrasound.

Authors:  Babak Nazer; Edward P Gerstenfeld; Akiko Hata; Lawrence A Crum; Thomas J Matula
Journal:  J Interv Card Electrophysiol       Date:  2013-12-03       Impact factor: 1.900

Review 5.  Pathophysiological mechanisms of high-intensity focused ultrasound-mediated vascular occlusion and relevance to non-invasive fetal surgery.

Authors:  C J Shaw; G R ter Haar; I H Rivens; D A Giussani; C C Lees
Journal:  J R Soc Interface       Date:  2014-03-26       Impact factor: 4.118

6.  Microbubble-Facilitated Ultrasound Catheter Ablation Causes Microvascular Damage and Fibrosis.

Authors:  Babak Nazer; David Giraud; Yan Zhao; Yue Qi; O'Neil Mason; Peter D Jones; Chris J Diederich; Edward P Gerstenfeld; Jonathan R Lindner
Journal:  Ultrasound Med Biol       Date:  2020-10-20       Impact factor: 2.998

7.  High-intensity ultrasound catheter ablation achieves deep mid-myocardial lesions in vivo.

Authors:  Babak Nazer; David Giraud; Yan Zhao; James Hodovan; Miriam R Elman; Ahmad Masri; Edward P Gerstenfeld; Jonathan R Lindner
Journal:  Heart Rhythm       Date:  2020-12-29       Impact factor: 6.343

8.  Ventricular arrhythmias in nonischemic cardiomyopathy.

Authors:  Fa-Po Chung; Chin-Yu Lin; Yenn-Jiang Lin; Shih-Lin Chang; Li-Wei Lo; Yu-Feng Hu; Ta-Chuan Tuan; Tze-Fan Chao; Jo-Nan Liao; Yao-Ting Chang; Ting-Yung Chang; Chung-Hsing Lin; Abigail Louise D Te; Shinya Yamada; Shih-Ann Chen
Journal:  J Arrhythm       Date:  2018-03-07
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.